1.87BMarket Cap
LossP/E TTM
Mesoblast Ltd's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Mesoblast Ltd is 7.41, ranking 174 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -16.76, which is -100.00% below the recent high of 0.00 and -47.92% above the recent low of -24.78.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.